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Background. A lack of an aetiologically based nosology classification has contributed to instability in psychiatric diag-
noses over time. This study aimed to examine the diagnostic stability of psychosis diagnoses using data from an inci-
dence sample of psychosis cases, followed up after 10 years and to examine those baseline variables which were
associated with diagnostic change.
Method. Data were examined from the ÆSOP and ÆSOP-10 studies, an incidence and follow-up study, respectively, of
a population-based cohort of first-episode psychosis cases from two sites. Diagnosis was assigned using ICD-10 and
DSM-IV-TR. Diagnostic change was examined using prospective and retrospective consistency. Baseline variables asso-
ciated with change were examined using logistic regression and likelihood ratio tests.
Results. Slightly more (59.6%) cases had the same baseline and lifetime ICD-10 diagnosis compared with DSM-IV-TR
(55.3%), but prospective and retrospective consistency was similar. Schizophrenia, psychotic bipolar disorder and
drug-induced psychosis were more prospectively consistent than other diagnoses. A substantial number of cases with
other diagnoses at baseline (ICD-10, n = 61; DSM-IV-TR, n = 76) were classified as having schizophrenia at 10 years.
Many variables were associated with change to schizophrenia but few with overall change in diagnosis.
Conclusions. Diagnoses other than schizophrenia should to be regarded as potentially provisional.
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Introduction
Diagnosis in psychiatry has frequently come under
fire. Robins & Guze (1970) discussed how clinical fea-
tures, outcome and family history can be used to create
nosological categories in the absence of clinical tests.
The National Institute of Mental Health recently criti-
cized the validity of the Diagnostic and Statistical
Manual of Mental Disorders (DSM), stating ‘Unlike
our definitions of ischemic heart disease, lymphoma,
or AIDS, the DSM diagnoses are based on a consensus
about clusters of clinical symptoms, not any objective
laboratory measure’ (Lane, 2013). This lack of aetio-
logically based psychiatric classification has contribu-
ted to instability in psychiatric diagnoses over time.
A number of studies have examined diagnostic sta-
bility over time. Early research was heterogeneous in
nature, reporting on differing diagnostic criteria, differ-
ent diagnostic processes and differing methods of
reporting results. More recently, however, researchers
have followed the lead of Schwartz et al. (2000) in
reporting prospective and retrospective consistencies
of diagnoses between two time points. Prospective
consistency is the proportion of cases that receives a
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diagnosis at baseline and retains that diagnosis at
follow-up. Retrospective consistency is the proportion
of cases that receives a diagnosis at follow-up that
they also had at baseline.
The prospective consistencies of schizophrenia and
bipolar affective disorder have been reported at
80–100% in studies with up to 4 years of follow-up
using first admission or first contact samples and
more recent criteria [International Classification of
Diseases (ICD)-10 or DSM-III onwards] (Amin et al.
1999; Schwartz et al. 2000; Veen et al. 2004; Baldwin
et al. 2005; Whitty et al. 2005; Salvatore et al. 2009,
2011). Studies with shorter follow-up periods report
that diagnoses are more stable over time. Longer-
term follow-up of the cohorts, identified by the
Determinants of Outcome of Severe Mental Disorder
(DOSMeD), World Health Organization Collaborative
Study on the Assessment and Reduction of Social
Disability (RAPyD) and International Pilot Study of
Schizophrenia (IPSS) samples reported by Craig et al.
(2007) identified prospective consistencies for schizo-
phrenia of about 85% over 12–26 years of follow-up,
using ICD-10 diagnoses converted using a World
Health Organization algorithm from previous classifi-
cation systems. Bromet et al. (2011) reported on the
10-year follow-up of a first admission cohort and iden-
tified similar diagnostic stability findings for schizo-
phrenia and bipolar affective disorder.
Findings with regards to other psychotic categories
are more variable. Depressive psychosis prospective
consistencies are reported to be between 45 and 55%
(Baca-Garcia et al. 2007a, b; Bromet et al. 2011) in long-
term follow-up studies (10–12 years), compared with
75–100% in shorter-term follow-up studies (1.5–4
years; Schwartz et al. 2000; Schimmelmann et al. 2005;
Whitty et al. 2005; Salvatore et al. 2009, 2011). Smaller
diagnostic categories (where studied) demonstrate
more variation still. Schizo-affective disorder, for ex-
ample, has reported prospective consistencies ranging
from 35% (Schwartz et al. 2000; Craig et al. 2007) to
95–100% (Schimmelmann et al. 2005; Salvatore et al.
2011). This variation probably reflects differences in
the diagnostic system adopted, cohort (first contact v.
first hospitalization) and length of follow-up. Further
studies have attempted to address stability in less
prevalent diagnoses such as acute and transient psych-
osis. These studies also show considerable variability
in prospective consistency: 30% (Aadamsoo et al.
2011); 73% (Sajith et al. 2002).
Many studies mentioned above used non-incidence
samples. Incidence studies give a less biased estimate
of diagnostic stability, as studies that recruit cases
from non-first-episode samples are effectively sampling
chronic cases in treatment, biasing the investigation to-
wards those who are more unwell and excluding others
who recover. One study has examined long-term diag-
nostic stability (13 years) in an incidence sample of
psychosis patients but only including schizophrenia
cases (Mason et al. 1997). To date, no study has yet
examined diagnostic stability of all psychosis diagnoses
specifically in incident cases over a follow-up period of
longer than 8 years using current diagnostic criteria.
Identification of predictors of diagnostic change over
time is important because predictors may aid in under-
standing why diagnoses change and indicate to clinical
teams when to be attentive to potential change and ad-
just treatment accordingly. Studies of relatively short
duration have examined predictors of diagnostic
change in an incidence cohort, but only one study
has looked at a long-term follow-up of diagnostic cat-
egories, in first admission cases (Schwartz et al. 2000;
Salvatore et al. 2009; Bromet et al. 2011).
In this study we sought to complement the knowl-
edge obtained from previous research, using a geo-
graphically defined incident sample of all psychoses
diagnoses made using DSM-IV-TR and ICD-10 criteria,
followed up and rediagnosed 10 years later, to fulfil
two main aims: (1) to examine the stability of diagnos-
tic categories 10 years after the first episode of psych-
osis; and (2) to examine which demographic and
clinical characteristics are associated with diagnostic
change.
Method
Baseline
This paper is based on data from the ÆSOP study
(Kirkbride et al. 2006; Morgan et al. 2014), an incidence
study of all first-episode psychosis cases presenting for
the first time to specialist mental health services in
defined catchment areas in Nottingham and London.
At baseline, clinical and demographic data were col-
lected from clinical records and, where possible, from
interview with cases using the Schedules for Clinical
Assessment in Neuropsychiatry (SCAN version 2;
World Health Organization, 1994) and the Personal
and Psychiatric History Schedule (World Health
Organization, 1996). The SCAN was used to elicit
symptom-related data at the time of presentation.
Where an interview with the patient was not possible,
case notes were used to complete the Item Group
Checklist (IGC) part of the SCAN. Case summaries
collated all relevant clinical information and were
made available to consensus diagnostic meetings
alongside the schedules above. ICD-10 (World Health
Organization, 1993) and DSM-IV-TR (American
Psychiatric Association, 2000) psychotic diagnoses
were determined using all available clinical informa-
tion (excluding clinical diagnosis) on the basis of
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consensus meetings involving at least one of the prin-
cipal investigators with other members of the research
team (at least one psychiatrist and one other member
of the research team). Conflicting opinions on diagno-
sis were discussed in detail until a consensus was
reached. This was made as soon as possible after first
contact (generally within a few weeks). Cases with a
dual diagnosis had their substance use disorder diag-
nosed separately. Diagnoses were made blind to ethni-
city. Factor analyses of the SCAN and IGC data
generated the following symptom dimensions: manic;
depressive; disorganized; negative; and reality distor-
tion (Demjaha et al. 2009).
Follow-up
Cases were followed up 10 years after first contact with
services in ÆSOP-10 (Morgan et al. 2014). The World
Health Organization Life Chart (Susser et al. 2000;
Harrison et al. 2001) was completed for each case
using case notes and clinical interview where possible,
to map course of illness and symptom history. The
SCAN was also completed in relation to the preceding
month where possible. Lifetime diagnosis (based on in-
formation from baseline to follow-up) using a consen-
sus approach was based on all this clinical information,
and blind to ethnicity and baseline diagnoses.
Ethical approval was granted by the Institute of
Psychiatry and South London and Maudsley (SLaM)
Research Ethics Committee and by the North
Nottingham Healthcare NHS Trust Ethics Committee.
Analyses
Data were analysed using STATA 10 (StataCorp, 2009).
Differences between followed-up and not-followed-up
cases were analysed using χ2 and Wilcoxon rank-sum
tests as appropriate. Prospective and retrospective con-
sistencies were calculated as the percentage of cases
with the same diagnosis at follow-up as at baseline,
and the percentage of cases with the same diagnosis
at baseline as at follow-up, respectively.
Predictors of diagnostic change were assessed in two
steps: unadjusted univariate logistic regression ana-
lyses; and models of independent predictors. Models
of independent predictors were built by starting with
a single variable and adding in additional variables,
one at a time to examine their effect on the model.
Only variables with p < 0.1 in the unadjusted analyses
were entered into the adjusted regression model start-
ing with the variable with the biggest effect. Each add-
itional variable was then added to the model in turn
using likelihood ratio tests to determine if that variable
significantly improved the model or not. Variables that
did not improve the model were excluded from the
model. Predictors were simplified into binary factors
where possible in order to simplify analyses and in-
crease power. As well as analysing age as a continuous
variable, it was reclassified into a binary variable (in
the age risk period: males under the age of 40 years
or females under the age of 50 years) as this has been
indicated as an important predictor in the develop-
ment of schizophrenia (Häfner et al. 1998).
Results
Sample
At baseline, a total of 557 first-episode psychosis cases
were identified. Data here are based on the incidence
sample collected over the first 2 years (excluding: non-
incidence cases collected for the brain imaging compo-
nent of the study; cases oversampled in the third year
in order to increase the numbers for the ethnicity com-
ponent of the study; and cases excluded post-baseline).
This led to a total number of 505 cases: 304 from
London and 201 from Nottingham.
Of the 505 patients eligible for follow-up, 79.8% (403)
had sufficient information to make a lifetime diagnosis
based on at least 8 years of information (including 33
cases who had died during the follow-up period but
had sufficient information to have a lifetime diagnosis
made). Therefore, a total of 102 cases had no follow-up
diagnostic information. The mean follow-up in years of
those who had a lifetime diagnosis and were still alive
was 10.74 years (S.D. = 1.17, range 8.08–13.70).
Table 1 shows the differences in demographic and
clinical variables between those with and without a
diagnosis at 8 or more years. Centre and place of
birth were associated with lifetime diagnosis status.
Cases who were born abroad were more likely to
move abroad over the follow-up period than cases
born in the UK and therefore less likely to be followed
up. More cases from London were not born in the UK
(38%, 112/297) compared with Nottingham (9%, 18/201;
p < 0.01), and so a lower lifetime diagnosis rate in
London could be linked to place of birth.
Diagnostic change: prospective and retrospective
consistency
Of cases, 59.6% (240/403) had the same baseline and
lifetime ICD diagnosis, and 55.3% (223/403) of cases
had the same baseline and lifetime DSM diagnosis. A
substantial proportion of patients had a baseline and
lifetime diagnosis of schizophrenia in both the ICD
(33%) and DSM (28%) (Tables 2 and 3). The DSM sys-
tem produced four cases with a baseline or lifetime
diagnosis of either ‘unknown’ or ‘other’. This was
due to the fact that although there was a large amount
of information for 8 or more years, the diagnostic team
was unable to agree upon a diagnosis.
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Table 4 presents the prospective and retrospective
consistency of the ICD-10 and DSM-IV-TR. The DSM
and ICD had very similar prospective consistencies
for most diagnoses, with schizophrenia, psychotic
bipolar disorder and drug-induced psychosis having
the highest prospective consistency. In terms of retro-
spective consistency, schizophrenia diagnosed using
the DSM had almost 10% lower consistency than
Table 1. Comparison of key variables between those with a diagnosis and those without a diagnosis
Test statistic
No diagnosis,
n (%) (n = 102)
Diagnosis,
n (%) (n = 403) χ2 (df)
Wilcoxon
Z p
Baseline diagnosis
Schizophrenia 41 (18.8) 177 (81.2) 2.088 (8) 0.973 (Fisher’s exact)
Delusional disorder 3 (13.6) 19 (86.4)
Acute and transient psychoses 7 (24.1) 22 (75.9)
Schizo-affective 6 (19.4) 25 (80.7)
Bipolar disorder and mania with
psychotic features
15 (21.4) 55 (78.6)
Major depression with psychotic
symptoms
17 (23.6) 55 (76.4)
Schizotypal personality disorder 0 (−) 1 (100)
Drug-induced psychoses 5 (19.2) 21 (80.8)
Psychoses NOS 8 (22.2) 28 (77.8)
Grouped diagnoses
Non-affective psychoses 70 (19.2) 293 (80.7) 0.7744 (2) 0.679
Bipolar disorder and mania with
psychotic features
15 (21.4) 55 (78.6)
Major depression with psychotic
symptoms
17 (23.6) 55 (76.4)
Centre
London 73 (24.0) 231 (76.0) 6.897 (1) 0.009
Nottingham 29 (14.4) 172 (85.6)
Gender
Male 63 (21.5) 230 (78.5) 0.736 (1) 0.391
Female 39 (18.4) 173 (81.6)
Ethnicity
White British 43 (18.9) 185 (81.1) 10.570 (5) 0.061
African-Caribbean 18 (15.1) 101 (84.9)
Black African 17 (26.2) 48 (73.9)
White other 10 (27.8) 26 (72.2)
Asian 3 (11.5) 23 (88.5)
Other 11 (35.5) 20 (64.5)
Place of birth
Non-UK born 35 (26.9) 95 (73.1) 4.800 (1) 0.028
UK born 66 (17.9) 302 (82.1)
Age at first contact, years −1.617 0.106
Median 27 29
IQR 22–33 22–36
Age at onset, years −1.597 0.110
Median 27 29.5
IQR 22–34 23–38
DUP, days −0.248 0.804
Median 56 60
IQR 15–184 15–238
df, Degrees of freedom; NOS, not otherwise specified; IQR, interquartile range; DUP, duration of undiagnosed psychosis.
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Table 2. ICD movement matrix
Baseline diagnosis (n)
Lifetime diagnosis (n) Schizophrenia
Schizo-affective
disorder
Delusional
disorder
Acute and
transient
psychoses
Bipolar disorder
and mania with
psychotic
features
Major
depression with
psychotic
features
Schizotypal
personality
disorder
Drug-induced
psychoses
Psychosis
NOS Total
Schizophrenia 133 8 12 7 2 15 1 3 13 194
Schizo-affective
disorder
16 9 0 0 3 3 0 1 5 37
Delusional disorder 0 0 3 1 0 2 0 0 0 6
Acute and transient
psychoses
1 1 0 4 2 1 0 1 0 10
Bipolar disorder and
mania with
psychotic features
7 3 0 1 42 7 0 0 1 61
Major depression
with psychotic
features
8 1 1 5 2 26 0 0 1 44
Schizotypal
personality disorder
0 0 0 0 0 0 0 0 1 1
Drug-induced
psychoses
5 1 0 5 2 0 0 16 0 29
Psychoses NOS 7 2 1 1 2 1 0 0 7 21
Total 177 25 17 24 55 55 1 21 28 403
ICD, International Classification of Diseases; NOS, not otherwise specified.
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Table 3. DSM movement matrix
Baseline diagnosis (n)
Lifetime
diagnosis (n) Schizophrenia
Schizo-affective
disorder
Major
depression
with
psychotic
features
Bipolar
disorder
and
mania
with
psychotic
features
Delusional
disorder
Psychosis
NOS Schizophreniform
Drug/
alcohol-induced
psychosis
Other
disorder Unclear
Brief
psychotic
disorder Total
Schizophrenia 113 8 15 2 12 13 17 4 1 1 3 189
Schizo-affective
disorder
13 6 4 3 0 5 1 0 0 0 0 32
Major depression
with psychotic
features
7 1 28 2 1 1 1 0 0 0 3 44
Bipolar disorder
and mania with
psychotic
features
7 2 9 42 0 1 0 0 0 0 1 62
Delusional
disorder
0 0 2 0 4 0 0 0 0 0 0 6
Psychosis NOS 6 3 1 3 1 8 1 0 0 0 1 24
Schizophreniform 3 0 0 0 1 1 3 0 0 0 0 8
Drug / alcohol
induced
psychosis
4 1 0 2 2 1 2 16 0 0 1 29
Other disorder 1 0 0 0 0 0 0 0 0 0 0 1
Unclear 0 0 0 0 0 0 0 0 0 0 1 1
Brief psychotic
disorder
1 0 1 1 0 0 0 1 0 0 3 7
Total 155 21 60 55 21 30 25 21 1 1 13 403
DSM, Diagnostic and Statistical Manual of Mental Disorders; NOS, not otherwise specified.
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schizophrenia diagnosed using the ICD. This differ-
ence is accounted for by the use of schizophreniform
disorder in the DSM but not in the ICD.
Drug-induced psychosis had a marginally higher pro-
spective consistency compared with schizophrenia
when using both the ICD and DSM. There were
more cases at follow-up than at baseline with the fol-
lowing diagnoses: schizophrenia, schizo-affective dis-
order, bipolar disorder and drug-induced psychosis.
Predictors of change
The unadjusted regression analyses for key baseline
demographic, clinical and social variables revealed
that five baseline variables were associated with
change in ICD diagnosis (see online Supplementary
Appendix S1 for full details). Likelihood ratio tests
revealed that the variables which together created the
most parsimonious model associated with change
were: having a diagnosis of delusional disorder
[odds ratio (OR) 23.42, 95% confidence interval (CI)
4.15–132.03], acute and transient psychosis (OR 73.84,
95% CI 8.52–639.80), schizo-affective disorder (OR
9.00, 95% CI 2.33–34.71) or psychosis not otherwise
specified (NOS) (OR 12.74, 95% CI 2.24–72.39);
being from London (Nottingham: OR 0.50, 95% CI
0.25–1.04); and having depressive symptoms (OR
1.92, 95% CI 1.11–3.32).
Eight baseline variables were associated with change
in DSM diagnosis in the unadjusted analyses.
Likelihood ratio tests revealed that the variables
which together created the most parsimonious model
of change were: having a diagnosis of psychotic
major depression (OR 2.54, 95% CI 0.87–7.41), schizo-
affective disorder (OR 12.21, 95% CI 2.16–69.00),
delusional disorder (OR 40.02, 95% CI 6.39–250.73),
psychosis NOS (OR 22.95, 95% CI 3.88–135.76)
and brief psychotic disorder (OR 39.38, 95% CI
3.53–439.13); being from London (Nottingham: OR
0.46, 95% CI 0.22–0.98); having a lower age at onset
(OR 0.17, 95% CI 0.05–0.54); having contact with
friends (less than weekly contact with friends: OR
0.34, 95% CI 0.13–0.90); and having depressive symp-
toms (OR 2.35, 95% CI 1.30–4.26).
Predictors of change to schizophrenia
Considering the high number of cases moving to a
diagnosis of schizophrenia over the follow-up period
and the implied increase in need this may engender
(Carr et al. 2004), a separate analysis of predictors of
change to a diagnosis of schizophrenia was under-
taken. This is shown in Table 5. For the ICD analyses,
all diagnoses were used. However, given the overlap
between DSM-IV-TR schizophreniform psychosis and
schizophrenia, schizophreniform cases were excluded
from the DSM analysis.
The unadjusted analyses revealed that many more
variables were associated with ICD and DSM diagno-
sis change to schizophrenia. For the ICD, there was
some evidence that 14 baseline variables were asso-
ciated with a change to schizophrenia. There was
strong evidence that the following were associated
with change to schizophrenia: being from London
(Nottingham OR 0.31, 95% CI 0.16–0.58); being in the
age risk period (OR 3.43, 95% CI 1.16–10.14); being
black African (OR 3.03, 95% CI 1.25–7.35); longer dur-
ation of undiagnosed psychosis (DUP) (OR 1.16, 95%
CI 0.99–1.35); having symptoms of reality distortion
(OR 1.73, 95% CI 1.07–2.81); having negative
Table 4. Prospective and retrospective consistency
Prospective consistency, %
(baseline number)
Retrospective consistency, %
(follow-up number)
Diagnosis DSM ICD DSM ICD
Schizophrenia 72.9 (155) 75.1 (177) 59.8 (189) 68.6 (194)
Bipolar disorder and mania with psychotic features 76.4 (55) 76.4 (55) 67.7 (62) 68.9 (61)
Major depression with psychotic features 46.7 (60) 47.3 (55) 63.6 (44) 59.1 (44)
Schizo-affective disorder 28.6 (21) 36.0 (25) 18.8 (32) 24.3 (37)
Delusional disorder 19.0 (21) 17.6 (17) 66.7 (6) 50.0 (6)
Drug-induced psychoses 76.2 (21) 76.2 (21) 55.2 (29) 55.2 (29)
Psychoses NOS 26.7 (30) 25.0 (28) 33.3 (24) 33.3 (21)
Schizophreniform 12.0 (25) – 37.5 (8) –
Brief/acute and transient psychoses 23.1 (13) 16.7 (24) 37.5 (7) 40.0 (10)
DSM, Diagnostic and Statistical Manual of Mental Disorders; ICD, International Classification of Diseases; NOS, not other-
wise specified.
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Table 5. Predictors of diagnostic change to schizophrenia using the ICD and DSM
Predictor
ICD unadjusted OR
(95% CI) Predictor
DSM unadjusted OR
(95% CI)
Demographics
Centre (n = 226) Centre (n = 223)
London – London –
Nottingham 0.31 (0.16–0.58)** Nottingham 0.34 (0.18–0.65)**
Gender (n = 226) Gender (n = 223)
Male – Male –
Female 0.57 (0.31–1.03)* Female 0.50 (0.27–0.92)**
Log age (n = 226) 0.62 (0.25–1.50) Log age (n = 223) 0.49 (0.20–1.23)
In the age risk period (n = 226) In the age risk period (n = 223)
No – No –
Yes 3.43 (1.16–10.14)** Yes 3.46 (1.17–10.24)**
Ethnicity (n = 226) Ethnicity (n = 223)
White British – White British –
African-Caribbean 1.50 (0.70–3.22) African-Caribbean 1.32 (0.61–2.87)
Black African 3.03 (1.25–7.35)** Black African 2.77 (1.15–6.65)**
White other 2.36 (0.62–8.99) White other 2.31 (0.60–8.80)
Asian 0.97 (0.25–3.72) Asian 1.04 (0.27–4.05)
Other 0.79 (0.16–3.87) Other 0.38 (0.05–3.18)
Clinical
Diagnosis (n = 225) Diagnosis (n = 221)
Psychoses NOS – Brief psychotic disorder –
Delusional disorder 1.98 (0.60–6.51) Major depression with
psychotic features
1.11 (0.27–4.58)
Acute and transient psychoses 0.54 (0.17–1.73) Bipolar disorder andmaniawith
psychotic features
0.13 (0.02–0.85)**
Schizo-affective 0.54 (0.18–1.67) Schizo-affective 2.05 (0.43–9.78)
Bipolar disorder andmaniawith
psychotic features
0.04 (0.01–0.21)** Delusional disorder 4.44 (0.94–21.00)*
Major depression with
psychotic features
0.43 (0.17–1.12)* Psychoses NOS 2.55 (0.58–11.18)
Schizotypal personality
disorder
– Drug-induced psychoses 0.78 (0.14–4.24)
Drug-induced psychoses 0.19 (0.05–0.80)** Other disorder –
Unknown/unclear –
Family history of psychosis
(n = 158)
Family history of psychosis
(n = 157)
No – No –
Yes 1.07 (0.47–2.46) Yes 1.39 (0.61–3.16)
Log DUP, days (n = 219) 1.16 (0.99–1.35)* Log DUP, days (n = 216) 1.14 (0.98–1.33)*
Log age of onset (n = 219) 0.65 (0.27–1.57) Log age of onset (n = 216) 0.51 (0.21–1.27)
Any drug use at baseline (n = 207) Any drug use at baseline (n = 204)
No use – No use –
Use 0.83 (0.45–1.56) Use 0.97 (0.52–1.82)
Mode of onset (n = 200) Mode of onset (n = 195)
Sudden – Sudden –
Acute 0.63 (0.25–1.57) Acute 0.56 (0.22–1.42)
Insidious 1.32 (0.61–2.86) Insidious 1.22 (0.56–2.66)
Symptom dimension–log (n = 202)
mania
0.35 (0.21–0.57)** Symptom dimension–log (n = 201)
mania
0.37 (0.23–0.60)**
Symptom dimension–log (n = 202)
reality distortion
1.73 (1.07–2.81)** Symptom dimension–log (n = 201)
reality distortion
1.77 (1.08–2.91)**
Symptom dimension–log (n = 202)
negative
1.84 (1.15–2.93)** Symptom dimension–log (n = 201)
negative
1.77 (1.10–2.87)**
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symptoms (OR 1.84, 95% CI 1.15–2.93); living along
(not living alone OR 0.49, 95% CI 0.26–0.89); being sin-
gle (not single OR 0.27, 95% CI 0.12–0.59); and having
contact with friends less than weekly (OR 4.49, 95% CI
1.54–13.05).
There was strong evidence that the following base-
line variables were associated with not changing diag-
nosis to schizophrenia: having a diagnosis of bipolar
disorder (OR 0.04, 95% CI 0.01–0.21) or drug-induced
psychoses (OR 0.19, 95% CI 0.05–0.80); and having
manic symptoms (OR 0.35, 95% CI 0.21–0.57).
There was some weak evidence that the following
were associated with changing to a diagnosis of schizo-
phrenia: being male (female OR 0.57, 95% CI
0.31–1.03); having psychotic major depression (OR
0.43, 95% CI 0.17–1.12); being unemployed (other OR
0.55, 95% CI 0.28–1.06); and not being in further educa-
tion (further education OR 0.52, 95% CI 0.25–1.11).
For the DSM, there was some evidence that 13 base-
line variables were associated with a change to schizo-
phrenia. There was strong evidence that the following
were associated with change to schizophrenia: being
from London (Nottingham OR 0.34, 95% CI 0.18–0.65);
being male (female OR 0.50, 95% CI 0.27–0.92); being
in the age risk period (OR 3.46, 95% CI 1.17–10.24);
being black African (OR 2.77, 95% CI 1.15–6.65); having
a diagnosis of delusional disorder (OR 4.44, 95% CI
0.94–21.00); having symptoms of reality distortion (OR
1.77, 95% CI 1.08–2.91); having negative symptoms
(OR 1.77, 95% CI 1.10–2.87); living alone (not living
alone OR 0.47, 95% CI 0.25–0.87); being single (not
being single OR 0.28, 95% CI 0.13–0.61); not being in fur-
ther education (further education OR 0.46, 95% CI 0.21–
0.99); and having contact with friends less than weekly
(OR 3.50, 95% CI 1.24–9.85).
There was strong evidence that the following were
associated with not changing diagnosis: having a diag-
nosis of bipolar disorder (OR 0.13, 95% CI 0.02–0.85);
and having manic symptoms (OR 0.37, 95% CI
0.23–0.60). There was some weak evidence that longer
DUP was associated with changing diagnosis (OR 1.14,
95% CI 0.98–1.33). For both the ICD and DSM, the num-
bers were too small to perform multivariate analyses.
Discussion
The prospective consistencies of both diagnostic sys-
tems were comparable at 55–60%. Few demographic,
Table 5 (cont.)
Predictor
ICD unadjusted OR
(95% CI) Predictor
DSM unadjusted OR
(95% CI)
Symptom dimension–log (n = 202)
depression
1.03 (0.68–1.56) Symptom dimension–log (n = 201)
depression
1.09 (0.72–1.66)
Symptom dimension–log (n = 202)
disorganization
0.73 (0.37–1.46) Symptom dimension–log (n = 201)
disorganization
0.70 (0.35–1.41)
Social
Living situation (n = 223) Living situation (n = 220)
Alone – Alone –
Not alone 0.49 (0.26–0.89)** Not alone 0.47 (0.25–0.87)**
Relationship status (n = 218) Relationship status (n = 215)
Single – Single –
Not single 0.27 (0.12–0.59)** Not single 0.28 (0.13–0.61)**
Highest education level (n = 220) Highest education level (n = 218)
School – School –
Further 0.52 (0.25–1.11)* Further 0.46 (0.21–0.99)**
Higher 0.61 (0.25–1.53) Higher 0.60 (0.24–1.50)
Employment status (n = 218) Employment status (n = 215)
Unemployed – Unemployed –
Other 0.55 (0.28–1.06)* Other 0.64 (0.33–1.22)
Contact with friends (n = 148) Contact with friends (n = 147)
Daily – Daily –
Weekly 2.24 (0.76–6.56) Weekly 1.88 (0.67–5.28)
Less than weekly 4.49 (1.54–13.05)** Less than weekly 3.50 (1.24–9.85)**
ICD, International Classification of Diseases; DSM, Diagnostic and Statistical Manual of Mental Disorders; OR, odds ratio;
CI, confidence interval; NOS, not otherwise specified; DUP, duration of undiagnosed psychosis.
* p < 0.1, ** p < 0.05.
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clinical and social factors were associated with overall
change in diagnosis but many factors were associated
with change to schizophrenia in both DSM and ICD
analyses. However, low numbers did not allow for
multivariate analysis of variables associated with
change to schizophrenia.
Strengths and limitations
As with most cohort studies, loss to follow-up is a po-
tential bias. Not all incident cases could be given a life-
time diagnosis. However, there was no difference in
the proportions followed up between the diagnoses
and the overall prevalence of follow-up was respect-
able at 80%. A further limitation was that missing
data in the predictors of change analysis limited the
power of the analyses. Despite these limitations, this
study contributes evidence beyond previous research
because of the incidence sample and 10-year follow-up
using both the ICD and DSM diagnoses. Furthermore,
it is based on consensus diagnoses made blind to eth-
nicity and baseline diagnoses and is the first study to
examine so many potential predictors of diagnostic
change across a range of domains (demographic, clin-
ical and social).
Findings and implications
An important finding was that schizophrenia, schizo-
affective disorder, bipolar disorder and drug-induced
psychosis had higher numbers at follow-up, indicating
a tendency for other diagnoses to migrate to these cat-
egories. This means that the incidence of these diagno-
ses may be underestimated in incidence studies and
this may confuse the aetiological picture.
The prospective consistencies for schizophrenia, bi-
polar disorder and drug-induced psychosis were sign-
ificantly higher than the overall stability (>70%). The
high stability of drug-induced psychosis is surprising.
This category represents a specific subgroup of indivi-
duals who demonstrate a clear temporal relationship
between onset and recovery of psychotic symptoms
and substance use. Rates of co-morbid substance mis-
use are significant in first-episode psychosis cohorts
at around 30–50% (Cantwell et al. 1999; Van Mastrigt
et al. 1999; Barnett et al. 2007), whereas drug-induced
psychosis often represents less than 10% of a
first-episode psychosis cohort (Whitty et al. 2005;
Addington et al. 2006; Bromet et al. 2011). This suggests
that often drug use is considered by assessors to be co-
morbid rather than a sole cause of first-episode psych-
osis but that where it is identified to be the sole cause,
this is often correct.
Depressive psychosis shows lower prospective con-
sistency (45–50%). This might be expected given the
anticipation that a substantial percentage of cases
will develop bipolar affective disorder over time.
However, approximately twice as many cases eventu-
ally receive a diagnosis of schizophrenia compared
with bipolar disorder. Previous literature is consistent
with this finding where consensus diagnosis was
used over long periods of follow-up (Bromet et al.
2011). It is well recognized that there are prominent
symptoms of both anxiety and depression in both pro-
dromal and early psychosis (Birchwood et al. 2000) and
this is further useful to clinicians considering treatment
and prognosis.
The minimal crossover between the bipolar and
schizophrenia categories illustrated in the movement
matrix is further supported by the finding that a diag-
nosis of bipolar disorder is associated with reduced
odds of changing diagnosis to schizophrenia over
time. This taken with the propensity of depressive
psychosis cases to change to schizophrenia suggests a
complicated relationship between affective and
‘so-called’ non-affective psychosis.
The prospective and retrospective consistencies of
the remaining categories were poor (<40%; with the ex-
ception of retrospective consistency for delusional dis-
order). Schizophreniform psychosis greatly overlaps
with schizophrenia (duration of symptoms being the
only difference) and explains the lower retrospective
consistency of the DSM-IV-TR schizophrenia category,
perhaps suggesting that it is an unnecessary extra cat-
egory. Delusional disorder has significantly higher
retrospective consistency (50–66%), suggesting less
crossover than the other unstable categories. The
movement matrix showed more than half of cases
with delusional disorder at baseline eventually receive
a diagnosis of schizophrenia, and the ICD analysis
revealed it is associated with changing diagnosis to
schizophrenia. Given this, it may best be considered
an attenuated form of schizophrenia.
Examination of the remaining categories in light of
their instability – schizo-affective disorder, acute/brief
psychosis and psychosis NOS – reveal no immediately
obvious patterns or utility in terms of describing a
course of symptoms. These categories represent approxi-
mately 15% of our sample (ICD 68 cases at baseline, 77
cases at follow-up; DSM-IV 64 cases at baseline, 63
cases at follow-up). This suggests that as well as lacking
aetiologically driven diagnoses in psychiatry, for a sign-
ificant minority of our patients we still lack an adequate
descriptive framework, a challenge for new and future
revisions of current classification systems.
Change to diagnosis of schizophrenia
While few characteristics were associated with diag-
nostic change in general, many factors were associated
with change to schizophrenia in both DSM and ICD
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analyses. Perhaps unsurprisingly, these included vari-
ables associated with schizophrenia: symptoms of real-
ity distortion, negative symptoms, and variables
indicative of social isolation: living alone, being single
and having contact with friends less than weekly.
However, low numbers did not allow for multivariate
analysis of variables associated with change to schizo-
phrenia. This is in line with previous research that has
reported negative symptoms (Mason et al. 1997) to be
associated with a change in diagnosis to schizophrenia.
The finding that social isolation (as measured by con-
tact with friends) was associated with change to
schizophrenia may be associated with negative symp-
toms, as less contact with friends could stem from
negative symptoms, and lead to isolation (Schwartz
et al. 2000).
Conceptual considerations
The findings from this and other studies on diagnostic
stability raise two salient issues. The first is validity:
there is an implicit assumption in papers on diagnosis
that patients exhibiting stable diagnoses will demon-
strate the same as-yet undiscovered physiological ab-
normalities. The finding that a number of diagnoses
change over time is assumed to mean that the initial
diagnosis was incorrect and thus the diagnostic sys-
tems are flawed, hence research into the causes of
these conditions will be hampered. However, in the
context of wider medicine, it is a common occurrence
for diagnosis to change over time as a disorder devel-
ops, or as the clinical picture emerges. It is common
that an acute condition precedes a chronic condition,
for example, demyelination and multiple sclerosis. In
this case, even information on aetiology and mechan-
ism do not indicate outcome, as the mechanism for
chronicity is separate. After an initial episode of this
neuro-inflammatory disorder, there is little certainty
as to prognosis – some people never relapse, for
others further episodes occur and the diagnosis
becomes multiple sclerosis (McDonald & Compston,
2001). That acute cases of demyelination reoccur and
can lead to a diagnosis of multiple sclerosis does not
undermine the usefulness of this diagnosis.
This brings us to the second issue of clinical utility. It
can be argued that diagnosis informs clinical manage-
ment of the patient and is therefore useful. However,
these results indicate that changes in diagnosis that
would probably result in a change of management
(e.g. from schizophrenia to bipolar disorder) are min-
imal, and the changes that do occur are less likely to
result in a substantial change in management (e.g. de-
lusional disorder to schizophrenia). Therefore, it could
be argued that diagnosis is of little clinical relevance,
and specific symptom change is the important thing
to be aware of. However, knowledge of how these
diagnoses might change over time may prove clinically
useful for both doctors and patients in understanding
prognosis early in the course of an illness, and, as
ever, in quickly communicating the nature of a cluster
of symptoms between clinicians.
This raises the question of whether we should be ig-
noring diagnosis, giving no prognosis to patients and
families, and be treating based on symptoms rather
than diagnosis. In some early intervention practices,
it is now commonplace to assign a broad clinical diag-
nosis of psychosis early in the course of illness. This
avoids using stigmatizing terms such as schizophrenia
with its association with poor outcome, promoting the
recovery model, and being optimistic about outcomes.
It also acknowledges what we have demonstrated in
the current study: early on in the course of psychotic
illness, the precise diagnosis is often provisional.
However, previous research suggests that diagnosis
is very strongly associated with outcome (Hegarty
et al. 1994), and thus not to share this with patients
and their families could be unethical. Perhaps a better
approach would be to acknowledge the provisional na-
ture of initial diagnosis and be cautious in making
inferences regarding prognosis based on diagnosis, as
it may not reflect the long-term picture, and to be vigi-
lant for changes in the clinical picture.
The stability of the current classification systems var-
ies widely between diagnoses. Schizophrenia, bipolar
disorder, drug-induced psychosis, delusional disorder
and depressive psychosis all show relative stability
and consistent patterns of change where change does
occur. The findings on diagnostic change in depressive
and bipolar cases poses a challenge to the distinction of
affective/non-affective categories. Psychosis NOS,
schizo-affective disorder and acute/brief psychosis per-
form poorly, yet still provide the best-fit diagnosis for
15% of our cohort, posing a significant challenge in the
revision of these categories.
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